Delivery Order SPE2DR25D2218-SPE2DR26FX4F3
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $7,250.41 to AmerisourceBergen Drug Corp for the supply of Arimidex 1 mg tablets (30-count units) on January 7, 2026, with an ultimate completion date of January 8, 2026. This non-set-aside, firm fixed-price delivery order was competitively awarded and performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a subsidiary of parent company Cencora, Inc., serves as a critical...
- The Defense Logistics Agency awarded a delivery order valued at $4,894.46 to AmerisourceBergen Drug Corp for the supply of Arimidex 1 mg tablets (30-count units) under a firm fixed-price contract. The order was competitively awarded without a set-aside designation and is scheduled for completion by January 5, 2026. AmerisourceBergen's Corporate Office division, headquartered in Conshohocken, Pennsylvania, serves as the place of performance for this pharmaceutical delivery. This delivery order is...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $3,790.08 to Amerisourcebergen Drug Corp (parent company: Cencora, Inc.) on January 6, 2026, for the supply of Arimidex 1 mg tablets in quantities of 30. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and is scheduled for completion by January 7, 2026. The place of performance is Conshohocken, Pennsylvania, where Amerisourcebergen maintains its corporate headquarters and primary distribution...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $5,378.10 for Arimidex 1 mg tablets (30-count packaging) with a completion date of November 14, 2025. This non-competitive, firm fixed-price delivery order was awarded on November 13, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and critical federal medical procurement vendor...
- The Defense Logistics Agency awarded a $27,773.43 firm fixed-price delivery order to AmerisourceBergen Drug Corp for 30-count tablets of Arimidex 1 mg, with an ultimate completion date of January 12, 2026. This competitively awarded, non-set-aside contract was issued on January 9, 2026, with performance occurring at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a subsidiary of parent company Cencora, Inc., serves as a critical pharmaceutical distributor...
- The Defense Logistics Agency awarded a $7,213.21 delivery order contract to AmerisourceBergen Drug Corp for the supply of Arimidex 1 mg tablets (30-count packaging) on December 12, 2025, with completion scheduled for December 15, 2025. This competitively awarded, firm fixed-price contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), which carries a ceiling value of $999,999,999.00 and extends through...
- The Defense Logistics Agency awarded a delivery order valued at $35.85K to AmerisourceBergen Drug Corp (parent company: Cencora, Inc.) on January 12, 2026, for the supply of Arimidex 1 mg tablets in quantities of 30 units. This is a firm fixed-price contract with an ultimate completion date of January 13, 2026, and represents a non-set-aside award issued through competitive procurement. The work will be performed at the awardee's corporate office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a delivery order valued at $34,247.33 to AmerisourceBergen Drug Corp for the supply of Arimidex 1 mg tablets (30-count packaging) on December 8, 2025, with an ultimate completion date of December 9, 2025. This competitive award, utilizing firm fixed pricing with no set-aside designation, represents a direct fulfillment under the company's existing contract vehicle with DLA. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major...
- The Defense Logistics Agency awarded a $29,791.65 firm fixed-price delivery order to AmerisourceBergen Drug Corp for 30-count bottles of Arimidex 1 mg tablets, with an ultimate completion date of January 9, 2026. This non-set-aside contract was competitively awarded and performed from AmerisourceBergen's Conshohocken, Pennsylvania location. AmerisourceBergen Drug Corp operates as a subsidiary of Cencora, Inc., a major pharmaceutical distributor serving federal healthcare systems with...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $4,215.65 to AmerisourceBergen Drug Corp on November 14, 2025, for the supply of Arimidex 1 mg tablets (30 count). The award is non-competitive and issued under a firm fixed-price delivery order contract type, with an ultimate completion date of November 17, 2025. The place of performance is listed as AmerisourceBergen's corporate office in Conshohocken, Pennsylvania, where the company maintains its headquarters as a major...
- SPE2DR25D2218Indefinite Delivery Contract
- SPE2DR25D2218-SPE2DR26FX4F3Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $7,057.74 to AmerisourceBergen Drug Corp for the supply of Arimidex 1 mg tablets (30-count packages) with a completion deadline of January 13, 2026. This competitively awarded, firm fixed-price contract contains no set-aside designation and will be performed at the contractor's Conshohocken, Pennsylvania facility. AmerisourceBergen Drug Corp, a subsidiary of parent company Cencora, Inc., is a major pharmaceutical distributor serving federal medical procurement needs, particularly for military and veteran healthcare systems. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract with DLA Troop Support Medical (designated SPE2DX), a comprehensive global pharmaceutical support vehicle valued at $999,999,999.00 through December 2026. The underlying IDC enables the contractor to supply an extensive range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, including specialty medications, brand-name and generic drugs, vaccines, and related medical commodities across multiple therapeutic domains. The parent company, Cencora, Inc., also maintains a significant single-award IDC with DLA Troop Support Medical valued up to $999,999,999.00 through December 31, 2031.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $7.1k | 1/11/26 |